<DOC>
	<DOCNO>NCT01669122</DOCNO>
	<brief_summary>This randomize , single center , open label , single dose , four way crossover study fast healthy male subject compare pharmacokinetics nicotine follow administration 3 prototype 4mg nicotine lozenge internationally market 4mg nicotine lozenge . Blood sample draw pre-specified interval total 12 hour post dose treatment session plasma sample analyze nicotine level .</brief_summary>
	<brief_title>Pharmacokinetic Study 4 mg Nicotine Lozenge .</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>smoke commerciallymanufactured cigarette daily precede 12 month routinely smoke first cigarette within 30mins awaken . inability refrain smoke confinement period , smoke tobacco form commercially manufacture cigarette , subject use chew tobacco tobacco product commercially manufacture cigarette within 7 day dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>